Answer a short online questionnaire about your health, goals, medical history, and current medications.
2. Clinical review
An independent, licensed US physician reviews your consultation and decides whether GLP-1 treatment is appropriate.
3. Prescription if appropriate
If approved, your assigned clinician issues a prescription for the treatment that best fits your needs.
4. Delivery and ongoing support
Your treatment is delivered discreetly, with ongoing support for dose questions, side effects, and check-ins.
Product details
Description
Ozempic® (semaglutide) is a once-weekly injectable medicine developed by Novo Nordisk for the treatment of type 2 diabetes. Semaglutide mimics the natural hormone GLP-1, which regulates appetite and blood sugar levels — which is why Ozempic also reduces hunger and promotes a lasting feeling of fullness.
In the US, Ozempic is authorised for type 2 diabetes. The same active ingredient is available as Wegovy, which is specifically approved for weight management. Following your online consultation, your prescriber will recommend the most suitable option for you. Always discuss your medical history, existing conditions and potential drug interactions with a clinician before starting treatment.
